Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idacorp (IDA) Cash & Equivalents (2016 - 2025)

Idacorp (IDA) has disclosed Cash & Equivalents for 17 consecutive years, with $215.7 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 41.52% to $215.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $215.7 million through Dec 2025, down 41.52% year-over-year, with the annual reading at $215.7 million for FY2025, 41.52% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $215.7 million at Idacorp, down from $333.2 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $634.5 million in Q1 2025, with the low at $134.8 million in Q2 2023.
  • Average Cash & Equivalents over 5 years is $296.1 million, with a median of $250.0 million recorded in 2021.
  • The sharpest move saw Cash & Equivalents plummeted 55.96% in 2024, then soared 302.64% in 2025.
  • Over 5 years, Cash & Equivalents stood at $215.2 million in 2021, then decreased by 17.5% to $177.6 million in 2022, then surged by 84.39% to $327.4 million in 2023, then rose by 12.65% to $368.9 million in 2024, then crashed by 41.52% to $215.7 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $215.7 million, $333.2 million, and $474.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.